<DOC>
	<DOCNO>NCT01111266</DOCNO>
	<brief_summary>The purpose study determine in-vivo ultrafiltration coefficient different size xevonta High-Flux dialyzer follow FDA guideline .</brief_summary>
	<brief_title>Determination Vivo Ultrafiltration Coefficient ( KUF ) Patients With Chronic Kidney Disease ( CKD )</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<criteria>Written inform consent obtain patient parents/ guardian . Subject age &gt; = 18 Effective blood flow 350 ml/min dialysate flow 500 ml/min On hemodialysis minimum 3 month Use Cimino Goretex shunt Routine dialysistreatment 240 min Documented dialysis adequacy parameter stable past 3 month Plan dialyze participate hemodialysis centre least 3months duration . Free currently know unusual clot access problem Hepatitis B surface antigen ( HbsAg ) negative , document within past 90 day Hepatitis B surface antibody ( antiHBs ) positive . Anti Hepatitis C Virus ( AntiHCV ) negative , document within past 90 day Anti Human Immunodeficiency Virus ( Anti HIV ) negative , document within past 90 day Hematocrit ( HCT ) 25 40 % haemoglobin ( Hb ) less 8 g/dL , document 14 day prior first treatment Patients unable tolerate effective blood flow 350 ml/min Patients use catheter dialysis Pregnant nursing woman . Women childbearing potential must agree avoid pregnancy study period use hormonal contraception ( implantable ; patch ; oral ) and/ doublebarrier method ( double combination : IUD ; condom spermicidal gel ; diaphragm ; sponge ; cervical cap ) Previous plan extend absence participate hemodialysis centre Expected transplanted ( live relate donor ) within maximum 3 month study period Any serious medical condition disability , opinion investigator , would interfere treatment assessment preclude completion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>vivo KUF</keyword>
	<keyword>ÃŸ2M</keyword>
	<keyword>leptin</keyword>
</DOC>